{"disease":{"id":"mesolthelioma","name":"mesolthelioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01258868","title":"Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":44,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}